Cantor Fitzgerald reissued their overweight rating on shares of Zevra Therapeutics (NASDAQ:ZVRA – Free Report) in a research ...
Tenaya Therapeutics (NASDAQ:TNYA – Free Report) had its price target trimmed by Chardan Capital from $18.00 to $9.00 in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback